The Minor Consult podcast

S8 Ep2: Exploring AI Innovation: insitro CEO Daphne Koller On AI In Drug Discovery

0:00
39:10
Retroceder 15 segundos
Avanzar 15 segundos
Dean Lloyd Minor welcomes Daphne Koller, PhD, founder and CEO of insitro, for a conversation about AI’s potential to transform drug discovery. They discuss how machine learning algorithms can accelerate the drug design process, quickly identifying biological patterns and predicting outcomes. They also explore the challenges and opportunities of founding a startup in Silicon Valley, and how insitro’s collaborations with large pharmaceutical companies are advancing therapeutics for Amyotrophic lateral sclerosis (ALS) and other conditions.

Otros episodios de "The Minor Consult"